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INTRODUCTION
Cytogenetic investigation is currently a standard prenatal
diagnostic test. Prenatal cytogenetic analysis requires the iso-
lation of metaphase chromosomes and takes 7-14 days for the
final results (1). The length of time until the final results is
considered to be unfavorable to patients and physicians be-
cause it can impose additional burden on them. Aneuploi-
dies of 5 chromosomes (13, 18, 21, X, Y) account for 95%
of the chromosomal aberrations that cause infants born with
defects (2, 3). 
Fluorescen in situ Hybridization (FISH) was first intro-
duced as a potentially powerful tool in clinical cytogenetics
(4, 5). During the late 1980s and the early 1990s, technical
issues were the focus of research. Specific probes to determine
which cell types are suitable for the use with FISH, and for
more effective techniques for cell preparation and signal detec-
tion were studied intensively (6). Since 1993, the American
College of Medical Genetics (ACMG) has taken the position
that prenatal interphase FISH is worth investigating. In 1997,
the FDA cleared the AneuVysion assay (Vysis, Inc.) to enu-
merate chromosome 13, 18, 21, X, Y for prenatal diagnosis
(7). The use of interphase FISH for rapid prenatal diagnosis
of numerical chromosome abnormalities from direct prepa-
rations of amniocytes is now widespread (8, 9). Several major
clinical studies have addressed the accuracy of prenatal detec-
tion of the most common aneuploidy by FISH (10). 
FISH takes only 24-48 hr, costs about half of the conven-
tional cytogenetic technique, and offers an opportunity to
reduce anxiety through early decision making process. The
purpose of the current study was to determine the accuracy
of FISH in detection of aneuploidies in real clinical practice. 
MATERIALS AND METHODS 
The results of 130 amniotic fluid interphase FISH analy-
ses performed from 1997 to 2001 at Laboratory of Medical
Genetics at the Samsung Cheil Hospital were reviewed ret-
rospectively. FISH was offered as an adjunct to the standard
chromosome analysis at the request of the obstetrics staff and
patients among 6,278 prenatal amniocenteses. Patients with
prenatal procedure were interviewed for the consideration of
rapid analysis by FISH as the replacement of the standard
karyotyping. The limitations of the prenatal FISH analysis
were also explained to the patients in detail.
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Amniotic Fluid Interphase Fluorescence in situ Hybridization (FISH) for
Detection of Aneuploidy; Experiences in 130 Prenatal Cases
The major aneuploidies diagnosed prenatally involve the autosomes 13, 18, 21, and
sex chromosomes X and Y. Fluorescence in situ hybridization (FISH) allows rapid
analysis of chromosome copy number in interphase cells. We retrospectively re-
viewed 130 amniotic fluid interphase FISH analyses from January 1997 to Decem-
ber 2001. The review was done in order to assess the role of interphase FISH among
the patients who were at the risk of fetal aneuploidies. The sample was considered
to be aneuploid when 70% of or more than the total number of hybridized nuclei
displayed the same abnormal hybridization pattern for a specific probe. All of 130
cases but one met the criteria. The results were considered as informative and they
were obtained in 24-48 hr. The overall detection rate for aneuploidies was 100%
(2 cases of trisomy 21, 2 cases of trisomy 18, and 1 case of Turner syndrome). In
comparison to cytogenetics, the rates of both sensitivity and specificity were 100%.
The experiment demonstrates that FISH can provide a rapid and accurate clinical
method for prenatal identification of chromosome aneuploidies. The experiment can
also serve as an adjunctive test to  help cytogenetics to reduce significant amount
of emotional stress of patients and physicians through early decision making pro-
cess. 
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For each specimen, 2-4 mL of clear amniotic fluid was ap-
plied. The FISH analyses were performed on uncultured am-
niocytes, using DNA probes specific for chromosome 13, 18,
21, X, Y. Alpha satellite probes were applied for chromo-
somes 13, 18, X, Y. While locus specific probes were imple-
mented for chromosome 21 (Vysis, Illinois, U.S.A.). A min-
imum of 100 interphase nuclei with defined hybridization
signals were enumerated for each chromosome by two dif-
ferent technicians. 
Our analytic criteria were defined as disomic, when normal
signal patterns were observed in ≥ 80% of nuclei, and ane-
uploidy if ≥70% of the nuclei had abnormal signal patterns.
Results were reported as uninformative as the above criteria
were not met. The standard cytogenetic analysis was based
on the examination of G-banded chromosomes from at least
30 cultured metaphase cells from a minimum of two inde-
pendent cultures. The results of interphase FISH analyses
were compared to standard karyotype analyses from cultured
cells. 
The gestational age at amniocenteses and the indications
for testing were recorded. The indications were classified as
positive maternal serum screening test, abnormal ultrasono-
graphic finding, advanced maternal age, and others.
FISH results were reported to the referring physician as
they became available. The written report included: 1) a short
description of the technique including the specific probes
used, 2) the results of the test; numbers of signals for each
tested chromosome, 3) the ploidy status of chromosome 13,
18, 21, X, Y, 4) the interpretation of the results, 5) the lim-
itations of prenatal FISH analysis; FISH cannot detect struc-
tural chromosomal aberrations, mosaicism, and numerial
abnormalities other than on chromosome 13, 18, 21, X, Y,
6) the recommendation to wait for the full cytogenetic results
before implementing therapeutic action. 
RESULTS 
A total number of 130 prenatal samples (2%) were analyzed
among 6,278 amniocentesis in our cytogenetic laboratory
from January 1997 to December 2001. Maternal age varied
from 25 to 39 (mean value was 34 yr). Gestational age at the
time of the procedure varied from 14 to 23 (mean value was
17.5 weeks). 
The indications for interphase FISH analyses are shown in
Table 1. The main indications were positive maternal serum
screening test (50%) and ultrasonographic abnormalities
(37.9%). The indication for five aneuploidy were all fetal
ultrasound abnormality. 
The average length of time to obtain results varied from
24 to 48 hr for FISH, while the time varied from 2 to 3 weeks
for conventional karyotyping. FISH results were reported to
be significantly faster than those of karyotyping. 
The results of FISH analysis in comparison with convention-
al cytogenic karyotyping is stated in Table 2, 3. Among the
indications of abnormal ultrasographic finding, increased
nuchal fold thickness (6 cases), heart anomaly (3 cases), om-
phalocele (1 case), and choroids plexus cyst (8 cases) showed
normal results in FISH analyses. All of the 130 relevant nor-
mal and abnormal FISH results were confirmed by subse-
quent cytogenetic analysis with no false positives or nega-
tives. There were 5 true positive (2 cases of trisomy 21, 2
cases of trisomy 18, and 1 cases of Turner syndrome) and 1
inconclusive FISH result (due to insufficient number of
nuclei).
We demonstrated that uncultured amniotic cell derived
from a Down syndrome fetus showed two signals for chro-
mosome 13 and three for chromosome 21 (Fig. 1). 
Compared to cytogenetic studies, the sensitivity of the test
to detect trisomy 21, 18, 13 and sex chromosome aneuploi-
dies was 100%. Chromosomal abnormality, such as 45, XY,
Maternal serum screening positive 65 50 0
Abnormal ultrasound finding 49 37.9 5      
Advanced maternal age 10 7.6 0       
Rapid sexing 
(X-linked recessive disease) 2 1.5 0
Previous Down baby 4 3.0 0
Total 130 100 5
Indication No.* (%) Aneuploidy
�
Table 1. Indication for prenatal interphase FISH studies
Increased nuchal translucency 12 Trisomy 21 1
Nuchal fold thickness 6 Normal 0
Cystic hygroma 6 45,X0 1
Heart anomaly 3 Normal 0
Omphalocele 1 Normal 0
Choroid plexus cyst 8 Normal 0 
Multiple fetal anomaly 13 Trisomy 18 2
Trisomy 21 1
Total 49 5
Abnormal ultrasound finding No.* FISH results No.
�
Table 2. Abnormal ultrasound findings and interphase FISH
analyses
*Number of cases of FISH analyses performed. 
� Number of aneuploidy
in interphase FISH stidyes.
*Number of cases with abnormal ultrasound finding. 
� Number of chro-
mosomal abnormality in FISH analysis.
Trisomy 21 2
Trisomy 18 2
45,X 1
45,XY,t(13;14)pat 1
Total 6
Cytogenetic report No.*
Table 3. Chromosomal abnormality in cytogenetic study
*Number of chromosomal abnormality.t(13;14)pat. were not be detected by interphase FISH analy-
sis. 
DISCUSSION
Standard cytogenetic analysis of prenatal specimens detects
chromosome aneuploidies and rearrangements with over
99.5% accuracy. However, standard karyotyping must be
performed on metaphase cells, and therefore it takes culture
time for several days. Especially, waiting for chromosome anal-
ysis can be place significant emotional stress for the patients
and physicians (11). FISH performed on uncultured amni-
otic fluid cells, chorionic villous cells, and fetal blood cells
with DNA probes specific for chromosomes 13, 18, 21, X,
Y is used in several laboratories for rapid prenatal detection
of aneuploidies, as an adjunct to routine metaphase cytoge-
netics (12-19).
The main indication of cytogenetic analysis was the abnor-
mal ultrasonographic findings. It is proven to be effective
especially for those patients referred near the time limit when
termination of pregnancy is a considerable option (20). In
our study, the main indications of rapid FISH analysis were
positive maternal serum screening test (50%), abnormal ul-
trasonographic findings, and advanced maternal age with
maternal anxiety. In our institution, routine ultrasound for
fetal anatomy screening was performed around 20 weeks of
gestation. When they showed abnormal results, we preferred
to adapt percutaneous umbilical cord blood for rapid karyo-
typing. The decision was optimal, because it consumed only
3-5 days (21). The termination limit with lethal fetal anoma-
ly was 23 weeks and 6 days in our institution. 
Ward et al. reported that 9.8% of the FISH results were
uninformative. The cause of the failed hybridization or prob-
lematic results is due to insufficient number of nuclei for anal-
ysis in one or more chromosomes (22). We had only one incon-
clusive result with insufficient number of nuclei in two chro-
mosomes. This case was performed during the early stage of
our study. The overall detection rate was almost 100%. The
accuracy and reproducibility of FISH analyses was critically
dependent upon the specificity and sensitivity of the probes
(17, 18). The detection rate for aneuploidies was 100% in this
study. Neither false-positive nor false-negative FISH results
was found. 
Feldman et al. reported that the incidence of chromosomal
abnormalities in very high risk pregnancies is relatively high-
er (14%) than it is in low risk pregnancies. The most common
finding of the abnormal chromosomes are 13, 18, 21, X, Y
(76%) (20). The fetal anomaly detected by ultrasound is the
most significant risk factor for chromosomal abnormalities.
The incidence of aneuploidy of 13, 18, 21, X, Y was only 3.8%
in our study. The incidence of chromosome abnormality, other
than 13, 18, 21, X, Y, which would not have been detectable
by FISH showed 14 cases (12.6%) in 111 abnormal results in
Thein group (23). In our group, there was only one case (14.3%)
with clinically insignificant familial balanced translocation in
6 abnormal karyotype results. 
The major problems found among most studies were the
results of unsatisfactory criteria in interpretation of results.
The different cut-off points for the proportion of cells with
identical pattern of signals needed for diagnosis by FISH
were between 50-70% in different studies. In this study, the
cut-off points were 80% in disomic and 70% in aneuploidy.
The total number of cells needed for diagnosis were relative-
ly higher (100 cells) than that of other studies (50 to 100
cells). Two highly experienced technicians performed the
microscopic evaluation. 
Effective communication between the referring physician
and cytogenetics laboratory is essential to improving the in-
terpretation of FISH studies. An indication for a FISH test,
accompanied by description of the specific fetal abnormali-
ties diagnosed by ultrasound, may alert the clinical cytoge-
neticist, when a disomic, hybridization pattern is observed
in cases likely to have autosomal or sex chromosomal aneu-
ploidy. As shown in our study, rapid FISH was performed as
an adjunct to routine metaphase cytogenetics on 130 prena-
tal samples submitted during the 5-yr period, according to
the request of patients and physicians. The majority of an-
euploidies associated with positive maternal serum screen-
ing test and abnormal ultrasound findings are standard tri-
somies from 13, 18, 21, X, Y, all of which would be diag-
nosed correctly and rapidly by FISH. This present study
shows that FISH results can play an important role in coun-
seling and decision making, especially for those patients
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Fig. 1. Interphase nucleus from uncultured amniocytes by FISH
shows two green (13 chromosome) and three red (21 chromo-
some) signals.referred with severe emotional burden. 
This experience demonstrates that FISH can provide a ra-
pid and accurate clinical method for prenatal identification
of chromosome aneuploidies as an adjunctive test to cytoge-
netics. 
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